Evidence map›Paper›PMID 36696737›Full record

ArticleMolecular genetics and metabolism2023

Resting and total energy expenditure of patients with long-chain fatty acid oxidation disorders (LC-FAODs).

James P DeLany, Angela Horgan, Ashley Gregor, Jerry Vockley, Cary O Harding, Melanie B Gillingham

Open access · greenAbstract read
In one paragraph

Article in Molecular genetics and metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

James P DeLanyAdventHealth Orlando, Translational Research Institute, Orlando, FL, United States of America.
Angela HorganOregon Translational and Clinical Research Institute, Portland, Oregon, United States of America.
Ashley GregorDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon, United States of America.
Jerry VockleyDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America.
Cary O HardingDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon, United States of America.
Melanie B GillinghamDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon, United States of America. Electronic address: gillingm@ohsu.edu.
Oregon Health & Science University · USOregon Research Institute · USTranslational Research Institute for Metabolism and Diabetes · USUniversity of Pittsburgh · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
Oregon Clinical and Translational Research InstituteUL1TR000128 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H · 2012 to 2015
$28.7M
Ph 2 Study of Triheptanoin for Tx of Long-Chain Fatty Acid Oxidation DisorderR01FD003895 · FDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI GILLINGHAM, MELANIE B · 2011 to 2014
$1.2M
Diet Therapy of Long-Chain Fatty Acid Oxidation DefectsF32DK065400 · NIDDK · OREGON HEALTH AND SCIENCE UNIVERSITY · PI GILLINGHAM, MELANIE B · 2004 to 2005
$82k
FDA HHS R01 FD003895NCATS NIH HHS UL1 TR000128NCATS NIH HHS UL1 TR001857NCATS NIH HHS UL1 TR002369NIDDK NIH HHS F32 DK065400
6 · The paper itself

Abstract

The basis of medical nutrition therapy for patients with LC-FAODs is to provide adequate energy to maintain anabolism and prevent catabolism. In practice, energy needs are estimated based on formulas derived from normal populations but it is unknown if energy expenditure among patients with LC-FAODs is similar to the normal population. We measured resting energy expenditure (REE), total energy expenditure (TEE) and body composition in 31 subjects with LC-FAODs ranging in age from 7 to 64 years. Measured REE was lower than estimated REE by various prediction equations and measured TEE was lower than estimated TEE. It is possible that the lower energy expenditure based on prediction formulas from the normal population is due to differences in body composition; we compared body composition to normal data from the 2017-18 National Health and Nutrition Examination Survey (NHANES). Fat free mass and fat mass was similar between subjects with an LC-FAOD and NHANES normal data suggesting no difference in body composition. We then compared measured REE and TEE to normal published data from the Dietary Reference Intakes (DRI). Measured REE and TEE were significantly lower among subjects with LC-FAODs compared to normal published energy expenditure data. Our results suggests patients with a LC-FAOD exhibit a lower REE and therefore actually have a slightly lower TEE than estimated. Current prediction equations may overestimate energy expenditure of patients with a LC-FAOD.

Indexed as

Lipid Metabolism, Inborn ErrorsAdolescentAdultBody CompositionCalorimetry, IndirectChildEnergy MetabolismFatty AcidsHumansMiddle AgedNutrition SurveysOxidation-ReductionYoung AdultFatty AcidsEnergy expenditureFatty acid oxidation disordersResting energy expenditureTotal energy expenditure

Identifiers

PMID36696737
PMCPMC9992335
OpenAlexW4317233615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.